The protein corona spontaneously develops and evolves on the surface of nanoscale
materials when they are exposed to biological environments, altering their physiochemical …

Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting
either the central nervous system or a variety of peripheral tissues. Structural and dynamic …

Pollution of micro/nano-plastics (MPs/NPs) is ubiquitously prevalent in the environment,
leading to an unavoidable exposure of the human body. Despite the protection of the blood …

The advent of genome editing has transformed the therapeutic landscape for several
debilitating diseases, and the clinical outlook for gene therapeutics has never been more …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the
dysfunction and progressive death of cerebral and spinal motor neurons. Preliminary …

Chiral assemblies of plasmonic nanoparticles are known for strong circular dichroism but not
for high optical asymmetry, which is limited by the unfavorable combination of electrical and …

Exposure to particulate matter (PM) pollution damages the human brain. Fossil fuel burning
for transportation energy accounts for a significant fraction of urban air and climate pollution …

Studies on the methods of nanoparticle (NP) synthesis, analysis of their characteristics, and
exploration of new fields of their applications are at the forefront of modern nanotechnology …

Preventing aggregation of amyloid beta (Aβ) peptides is a promising strategy for the
treatment of Alzheimer's disease (AD), and gold nanoparticles have previously been …

The blood-brain barrier (BBB) is one of the most essential protection mechanisms in the
central nervous system (CNS). It selectively allows individual molecules such as small lipid …